Autism Spectrum Disorder
📧 Sign up to get email alerts when something new happens for Autism Spectrum Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-06-21Clinical Trial Update: Pilot Study of Diet and Behavior in Children With Autism [NA]
A pilot clinical trial evaluating diet and behavior interventions in children with autism has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Early Characteristics of Autism [Phase 1]
This Phase 1 clinical trial update reports early characteristics of autism and autistic disorder conducted by the University of Washington; …
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Promoting Development in Toddlers With Communication Delays [NA]
Autism Speaks-sponsored clinical trial aiming to promote development in toddlers with communication delays related to autism has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Study of Fluoxetine in Autism [Phase 3]
Phase 3 trial evaluating fluoxetine for autism has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-13Clinical Trial Update: Pilot Study of the Effect of Hyperbaric Oxygen Treatment on Behavioral and Biomarker Measures in Children With Autism [Phase 3]
Phase 3 pilot study evaluating hyperbaric oxygen treatment on behavioral and biomarker outcomes in children with autism has completed, with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-02Clinical Trial Update: CBT for Comorbid Anxiety Disorders in Children With Autism, Asperger Syndrome, or PDD-NOS [Phase 2]
Phase 2 study assessing cognitive-behavioral therapy for anxiety disorders in children with autism spectrum disorders; the trial has complet…
-
FDA approval · 2012-03-12FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)
FDA approved a supplemental application for risperidone (Risperidone) by Janssen Pharmaceutical, Inc. The approval signals changes or additi…
-
FDA approval · 2012-03-01FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
The FDA granted Westminster Pharmaceuticals, LLC a supplemental approval for risperidone, updating the approved product's labeling.
-
FDA approval · 2012-02-21FDA Approved: RISPERIDONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for risperidone from Sun Pharmaceutical Industries, Inc. under an Abbreviated New Drug Application, …
-
FDA approval · 2012-01-30FDA Approved: RISPERIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for a generic risperidone product from Amneal Pharmaceuticals LLC. Risperidone is an antipsychot…
-
FDA approval · 2012-01-30FDA Approved: RISPERIDONE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic risperidone from Aurobindo Pharma Limited, granting approval for a generic version of …
-
CLINICAL_TRIALS withdrawal · 2012-01-10Clinical Trial Update: Fluoxetine Essay in Children With Autism [Phase 2]
A Phase 2 clinical trial evaluating fluoxetine in children with autism has been withdrawn.
-
CLINICAL_TRIALS research · 2012-01-06Clinical Trial Update: The Prevalence of Psychological and Medical Comorbidities Among Children Suffering From Autistic Spectrum Disorder and the Differences Between Ethnic Groups in Israel
A clinical trial update examining the prevalence of psychological and medical comorbidities among children with autism in Israel and how the…
-
FDA approval · 2012-01-03FDA Approved: RISPERIDONE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for risperidone from Zydus Lifesciences Limited, enabling changes to an already approved generic…
-
CLINICAL_TRIALS trial_result · 2011-12-21Clinical Trial Update: Efficiency of Bumetanide in Autistic Children [Phase 3]
Phase 3 trial evaluating the efficacy of bumetanide in children with autism spectrum disorder has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Autism Spectrum Disorders (ASD) Driving Study
Massachusetts General Hospital conducted a clinical trial evaluating driving performance in individuals with autism spectrum disorder. The s…
-
FDA approval · 2011-11-29FDA Approved: RISPERIDONE — Original Application (Solco Healthcare US, LLC)
The FDA approved the original application for a generic risperidone manufactured by Solco Healthcare US, LLC. The approval covers standard i…
-
FDA approval · 2011-11-15FDA Approved: RISPERIDONE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for risperidone by Chartwell RX, LLC, related to the generic product's labeling.
-
FDA approval · 2011-11-15FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approves Westminster Pharmaceuticals' supplemental application for risperidone (generic), updating its approved status under an ANDA.
-
FDA approval · 2011-11-10FDA Approved: RISPERIDONE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic risperidone product from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2011-10-14Clinical Trial Update: Safety and Efficacy of Stem Cell Therapy in Patients With Autism [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and efficacy of stem cell therapy in patients with autism has completed.
-
FDA approval · 2011-09-27FDA Approved: RISPERIDONE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for risperidone, granting approval of a generic risperidone product. This is …
-
FDA approval · 2011-09-24FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved Janssen's supplemental application for Risperdal M-TAB (risperidone), adding the M-TAB dosage form to the approved product.…
-
FDA approval · 2011-08-26FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Risperidone by Torrent Pharmaceuticals Limited, indicating approval of a generic version of the …
-
FDA approval · 2011-08-25FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' supplemental application for risperidone, authorizing a generic version of the antipsychotic. The …